Long‐term clinical and virological outcomes of chronic hepatitis C after successful interferon therapy
Authors:
- 14 September 2004
- journal article
- research article
- Published by Wiley in Journal of Medical Virology
- Vol. 74 (3) , 406-413
Abstract
Clinical relevance of occult hepatitis C virus (HCV) and/or hepatitis B virus (HBV) infection(s) remains uncertain years after interferon (IFN) therapy for chronic hepatitis C. By 1993, 38 sustained virological responders (SVRs) showing HCV RNA clearance at 6 months post‐treatment and 37 biochemical responders (BRs) with end‐of‐treatment alanine aminotransferase (ALT) normalization and subsequent 6‐month stabilization within 2 × the upper limit of normal (ULN) were enrolled. They were monitored for 4.4–12 years (median 6.8), then 15 SVRs and 15 BRs underwent paired liver biopsies. Biopsy samples were tested for positive and negative HCV RNA strands, and HBV DNA surface and X sequences. All SVRs showed sustained serum HCV RNA clearance during follow‐up, but hepatocellular carcinoma (HCC) developed in 4 (11%) SVRs. On paired liver biopsies, histological improvement was significant, but mild inflammation persisted in 87% of SVRs. Nonetheless, no HCV RNA sequence was amplified from liver tissues, and HBV DNA sequences were found in only one SVR. As for BRs, biochemical flare‐up of >2 × ULN occurred at a 5‐year risk of 41% (95% CI 24.7–56.4). The event was unpredictable but controllable by retreatment in 70%. Liver tissues after follow‐up contained positive and negative HCV RNA strands, but no HBV DNA sequence was amplified. These results suggest that SVRs, albeit free of occult HCV and/or HBV infection(s) over a decade, retain mild liver inflammation and the risk of HCC. Occult HBV was also shown uninvolved in flare‐up during follow‐up of BRs. J. Med. Virol. 74:406–413, 2004.Keywords
This publication has 22 references indexed in Scilit:
- Histological improvement of chronic liver disease after spontaneous serum hepatitis C virus clearanceJournal of Medical Virology, 2002
- Predictive value of ALT levels for histologic findings in chronic hepatitis C: A European collaborative studyHepatology, 2002
- Long–Term Follow–Up Study of Sustained Biochemical Responders With Interferon TherapyHepatology, 2001
- Occult Hepatitis B Virus Infection in Patients with Chronic Hepatitis C Liver DiseaseNew England Journal of Medicine, 1999
- Possible Contribution to Hepatocarcinogenesis of X Transcript of Hepatitis B Virus in Japanese Patients With Hepatitis C VirusHepatology, 1999
- Detection of Hepatitis C Virus in Paraffin–Embedded Liver Biopsies of Patients Negative for Viral Rna in SerumHepatology, 1999
- Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis CNew England Journal of Medicine, 1998
- 10-year follow-up after interferon-α therapy for chronic hepatitis CHepatology, 1998
- Histological grading and staging of chronic hepatitisJournal of Hepatology, 1995
- Avoiding false positives with PCRNature, 1989